Comparable targeted fluorescent techniques have been established in other tumour types, e.g. in ovarian carcinoma [17, 53] and peritoneal metastases of colorectal carcinomas [18] targeting αvβ3-integrin or folate receptor α and VEGF-α, respectively. This evidence concerns the gene VEGFA and neoplasm.